Clinical Trial Update: Radiation Therapy, Irinotecan, and Cetuximab in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Rectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating radiation therapy with irinotecan and cetuximab for patients undergoing surgery for stage III or stage IV rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Centre Hospitalier Universitaire Vaudois | Conditions: Colorectal Cancer | Phase 1 | Status: UNKNOWN